Authors: Nagai, M Kubota, R Greten, TF Schneck, JP Leist, TP Jacobson, S

Citation: M. Nagai et al., Increased activated human T cell lymphotropic virus type I (HTLV-I) tax11-19-specific memory and effector CD8(+) cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: Correlation with HTLV-I provirus load, J INFEC DIS, 183(2), 2001, pp. 197-205

Authors: Carruth, LM Greten, TF Murray, CE Castro, MG Crone, SN Pavlat, W Schneck, JP Siliciano, RF

Citation: Lm. Carruth et al., An algorithm for evaluating human cytotoxic T lymphocyte responses to candidate AIDS vaccines, AIDS RES H, 15(11), 1999, pp. 1021-1034

Authors: Greten, TF Jaffee, EM

Citation: Tf. Greten et Em. Jaffee, Cancer vaccines, J CL ONCOL, 17(3), 1999, pp. 1047-1060

Authors: Howard, MC Spack, EG Choudhury, K Greten, TF Schneck, JP

Citation: Mc. Howard et al., MHC-based diagnostics and therapeutics - clinical applications for disease-linked genes, IMMUNOL TOD, 20(4), 1999, pp. 161-165

Authors: Bieganowska, K Hollsberg, P Buckle, GJ Lim, DG Greten, TF Schneck, J Altman, JD Jacobson, S Ledis, SL Hanchard, B Chin, J Morgan, O Roth, PA Hafler, DA

Citation: K. Bieganowska et al., Direct analysis of viral-specific CD8(+) T cells with soluble HLA-A2/Tax11-19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy, J IMMUNOL, 162(3), 1999, pp. 1765-1771